LegoChem Biosciences Inc (141080) — Capital Reinvestment Ratio

Latest as of December 2024: 0.07x

LegoChem Biosciences Inc (141080) has a Capital Reinvestment Ratio of 0.07x as of December 2024, meaning it reinvests 0% of its operating cash flow (₩78.48 Billion) in capital expenditures (₩5.70 Billion). Check LegoChem Biosciences Inc (141080) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

₩78.48 Billion

KRW

Capital Expenditures

₩5.70 Billion

KRW

Data as of

Dec 2024

Most recent filing

LegoChem Biosciences Inc Capital Reinvestment Ratio (2019–2024)

This chart tracks LegoChem Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see LegoChem Biosciences Inc (141080) cash flow conversion.

Annual Capital Reinvestment Ratio for LegoChem Biosciences Inc (2019–2024)

Year-by-year Capital Reinvestment Ratio for LegoChem Biosciences Inc from 2019 to 2024. See 141080 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2024	0.07x	₩78.48 Billion	₩5.70 Billion	▼ -48.0%
2019	0.14x	₩24.11 Billion	₩3.37 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow